Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies

Karen A. Tourian, S. Krishna Padmanabhan, James Groark, Claudine Brisard, D. L. Farrington

Clinical Therapeutics · 2009 · 69 citations · 24 references

Concepts

References

24